Item(by='disabled', descendants=None, kids=None, score=None, time=1611721367, title=None, item_type='comment', url=None, parent=25923702, text='&gt; This idea that drugs should be cheap and accessible the moment they are approved is incompatible with economic reality.<p>I know that orphan drugs are lifesaving and it is life-and-death for the people who do and don’t receive them, but this is generally not true, including for orphan drugs. I know because I have 2 rare immune mediated neurological diseases affecting my peripheral nervous system and I take an orphan drug (blood product) known as subcutaneous immunoglobulin.<p>Soliris, one of the world’s most expensive drugs, costing ~$600,000&#x2F;year in countries with “socialized medicine” is estimated to cost less than 1% of that price to produce, as in less than $6,000&#x2F;year. This is from industry insiders who have technical experience. Not only that, it is estimated that 80-90% of the work was discovered on public, government funds. See at 11:30 \n<a href="https:&#x2F;&#x2F;youtu.be&#x2F;0uYCw5EDX8U" rel="nofollow">https:&#x2F;&#x2F;youtu.be&#x2F;0uYCw5EDX8U</a><p>I have a background in applied science and I agree that this is the general ballpark case for orphan drugs, based on reading patents.')